BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9113443)

  • 1. Successful reversal of acute vascular rejection in a renal allograft with combined mycophenolate mofetil and tacrolimus as primary immunotherapy.
    Ahsan N; Holman MJ; Katz DA; Abendroth CS; Yang HC
    Clin Transplant; 1997 Apr; 11(2):94-7. PubMed ID: 9113443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients.
    Sun Q; Liu ZH; Yin G; Chen H; Chen J; Ji S; Li LS
    Nephrol Dial Transplant; 2006 Feb; 21(2):510-7. PubMed ID: 16421166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primates.
    Nakamura K; Oshima S; Maeda M; Morio H; Fukahori H; Nakanishi T; Tsujimoto S; Hirose J; Noto T; Hamakawa N; Inami M; Morokata T
    Int Immunopharmacol; 2018 Nov; 64():201-207. PubMed ID: 30195818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Mycophenolate Mofetil Dose Reduction on Allograft Outcomes in Kidney Transplant Recipients on Tacrolimus-Based Regimens: A Systematic Review.
    Su VCh; Greanya ED; Ensom MH
    Ann Pharmacother; 2011 Feb; 45(2):248-57. PubMed ID: 21304036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil.
    Sun Q; Liu ZH; Cheng Z; Chen J; Ji S; Zeng C; Li LS
    Kidney Int; 2007 Jan; 71(1):24-30. PubMed ID: 16969384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation.
    Busque S; Shoker A; Landsberg D; McAlister V; Halloran P; Shapiro J; Peets J; Schulz M
    Transplant Proc; 2001; 33(1-2):1266-7. PubMed ID: 11267285
    [No Abstract]   [Full Text] [Related]  

  • 9. Tacrolimus and mycophenolate mofetil provide effective immunosuppression in rat laryngeal transplantation.
    Nelson M; Fritz M; Dan O; Worley S; Strome M
    Laryngoscope; 2003 Aug; 113(8):1308-13. PubMed ID: 12897551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing of MMF in combination with tacrolimus for steroid-resistant vascular rejection in pediatric renal allografts.
    Filler G; Lampe D; Mai I; Strehlau J; Ehrich JH
    Transpl Int; 1998; 11 Suppl 1():S82-5. PubMed ID: 9664950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.
    Vu MD; Qi S; Xu D; Wu J; Peng J; Daloze P; Sehgal S; Leduc B; Chen H
    Transplantation; 1998 Dec; 66(12):1575-80. PubMed ID: 9884242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressive drug monitoring of cyclosporine, tacrolimus, and mycophenolate mofetil in renal transplantation].
    Uchida K
    Nihon Jinzo Gakkai Shi; 2005; 47(4):423-9. PubMed ID: 15971884
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of FK 506, mycophenolate mofetil, and aminoguanidine effects on delay of corneal allograft rejection in an experimental model of low-risk and high-risk keratoplasty.
    Svozílková P; Bysterská P; Masek K; Valenta Z; Zvárová J; Farghali H
    Immunopharmacol Immunotoxicol; 2006; 28(2):335-40. PubMed ID: 16873100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring.
    Meiser BM; Pfeiffer M; Schmidt D; Reichenspurner H; Ueberfuhr P; Paulus D; von Scheidt W; Kreuzer E; Seidel D; Reichart B
    J Heart Lung Transplant; 1999 Feb; 18(2):143-9. PubMed ID: 10194038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival of an extremity composite tissue allograft with FK506-mycophenolate mofetil therapy.
    Jones JW; Ustüner ET; Zdichavsky M; Edelstein J; Ren X; Maldonado C; Ray M; Jevans AW; Breidenbach WC; Gruber SA; Barker JH
    Surgery; 1999 Aug; 126(2):384-8. PubMed ID: 10455910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys.
    Song L; Ma A; Dun H; Hu Y; Zeng L; Bai J; Zhang G; Kinugasa F; Sudo Y; Miyao Y; Okimura K; Miura T; Daloze P; Chen H
    Transplantation; 2014 Aug; 98(3):267-76. PubMed ID: 24992357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.
    Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Pellar S; Josephson MA; Thistlethwaite JR
    Transplant Proc; 1998 Mar; 30(2):507-8. PubMed ID: 9532150
    [No Abstract]   [Full Text] [Related]  

  • 18. First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation.
    Kahl A; Bechstein WO; Platz K; Müller A; Berweck S; Venz S; Neuhaus P; Frei U
    Transplant Proc; 1998 Mar; 30(2):505-6. PubMed ID: 9532149
    [No Abstract]   [Full Text] [Related]  

  • 19. Alefacept combined with tacrolimus, mycophenolate mofetil and steroids in de novo kidney transplantation: a randomized controlled trial.
    Rostaing L; Charpentier B; Glyda M; Rigotti P; Hettich F; Franks B; Houbiers JG; First R; Holman JM
    Am J Transplant; 2013 Jul; 13(7):1724-33. PubMed ID: 23730730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tacrolimus and mycophenolate mofetil combination on cardiovascular risk profile after kidney transplantation.
    Morales JM; Domínguez-Gil B
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S296-303. PubMed ID: 17130278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.